Mori Takahiro 森隆浩

Researcher Number	50384780
Other IDs
Affiliation (based on the past Project Information) *help	2023: 国際医療福祉大学, 医学部, 教授 2022: 国際医療福祉大学, 国際医療福祉大学成田病院, 教授 2021: 千葉大学, 大学院医学研究院, 特任准教授 2018 – 2020: 筑波大学, 医学医療系, 准教授 2017: 筑波大学, 医学医療系, 研究員
Review Section/Research Field	Principal Investigator Basic Section 58010:Medical management and medical sociology-related / Medical sociology
Keywords	Principal Investigator 大腿骨骨折 / 骨折予防 / 骨粗鬆症 / 医療経済学 / 医療介護レセプト研究 / 費用対効果分析 / 超高齢化社会 / テリパラチド / 年間医療費 / 骨粗鬆症薬物治療 … More / 脆弱性大腿骨近位部骨折 / 医療介護レセプト / レセプトデータ / レセプトデータ研究 / 介護費 / 医療費 / 医療経済研究 Less

Fracture Prevention in a Super-Aging Society: Insights from Studies of Health Incurance Claims Data and Cost-Effectiveness AnalysisPrincipal Investigator
- Principal Investigator
  
  Mori Takahiro
- Project Period (FY)
  2020 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 58010:Medical management and medical sociology-related
- Research Institution
  International University of Health and Welfare
  Chiba University
  University of Tsukuba
A Proposal for Effective Use and Reduction of Medical and Long-Term Care Expenditures: Big Data Analysis of Claims Data for Those Who Had Hip FracturePrincipal Investigator
- Principal Investigator
  
  Mori Takahiro
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical sociology
- Research Institution
  University of Tsukuba

All 2023 2022 2021 2020 2019 2018

All Journal Article Presentation

[Journal Article] Factors associated with non-initiation of osteoporosis pharmacotherapy after hip fracture: analysis of claims data in Japan2023
- Author(s)
  Fujii Tomoko、Mori Takahiro、Komiyama Jun、Kuroda Naoaki、Tamiya Nanako
- Journal Title
  
  Archives of Osteoporosis
  
  Volume: 18 Issue: 1 Pages: 103-103
- DOI
  10.1007/s11657-023-01314-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K10340
[Journal Article] Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database2022
- Author(s)
  Mori Takahiro、Komiyama Jun、Fujii Tomoko、Sanuki Masaru、Kume Keitaro、Kato Genta、Mori Yukiko、Ueshima Hiroaki、Matsui Hiroki、Tamiya Nanako、Sugiyama Takehiro
- Journal Title
  
  Archives of Osteoporosis
  
  Volume: 17 Issue: 1 Pages: 61-61
- DOI
  10.1007/s11657-022-01096-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K10340, KAKENHI-PROJECT-18H04076
[Journal Article] Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan2021
- Author(s)
  Takahiro Mori, Carolyn J. Crandall, Tomoko Fujii, David A. Ganz
- Journal Title
  
  Archives of Osteoporosis
  
  Volume: 16 Issue: 1 Pages: 113-113
- DOI
  10.1007/s11657-021-00956-z
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K10340
[Journal Article] Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan2021
- Author(s)
  Mori Takahiro、Crandall Carolyn J.、Fujii Tomoko、Ganz David A.
- Journal Title
  
  Archives of Osteoporosis
  
  Volume: 16 Issue: 1 Pages: 72-72
- DOI
  10.1007/s11657-021-00891-z
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K10340
[Journal Article] Cost-effectiveness of zoledronic acid versus oral alendronate for postmenopausal osteoporotic women in China2020
- Author(s)
  Ruxu You, Yu Zhang, David Bin-Chia Wu, Jinyu Liu, Xinyu Qian, Nan Luo and Takahiro Mori
- Journal Title
  
  Frontier in Pharmacology
  
  Volume: 11 Pages: 456-456
- DOI
  10.3389/fphar.2020.00456
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K08899
[Journal Article] Sequential Teriparatide/Alendronate versus Alendronate-only Strategies in High-risk Osteoporotic Women in the US: Analyzing the Impact of Generic or Biosimilar Teriparatide2019
- Author(s)
  Mori T, Crandall C.J., and Ganz A.D
- Journal Title
  
  JBMR Plus
  
  Volume: 3(11) Issue: 11
- DOI
  10.1002/jbm4.10233
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K08899
[Journal Article] Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged ≧75 years and long-term care insurance claims data in Japan2018
- Author(s)
  Takahiro Mori, Nanako Tamiya, Xueying Jin, Boyoung Jeon, Satoru Yoshie, Katsuya Iijima, Tatsuro Ishizaki
- Journal Title
  
  Archives of Osteoporosis
  
  Volume: 13:37 Issue: 1
- DOI
  10.1007/s11657-018-0448-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K08899
[Presentation] レセプトデータを用いた大腿骨近位部骨折後の骨粗鬆症薬物治療導入の有無に関連する要因の検討2023
- Author(s)
  藤井朋子　森隆浩　小宮山潤　黒田直明　田宮菜奈子
- Organizer
  第25回日本骨粗鬆症学会
- Data Source
  KAKENHI-PROJECT-20K10340
[Presentation] Cost-effectiveness of alendronate for 10 years compared with 5 years in Japan,2019
- Author(s)
  森　隆浩
- Organizer
  第78回日本公衆衛生学会学術総会
- Data Source
  KAKENHI-PROJECT-17K08899
[Presentation] Cost-effectiveness of sequential daily teriparatide/alendronate compared with alendronate alone for older osteoporotic women with prior vertebral fracture in Japan2019
- Author(s)
  森　隆浩
- Organizer
  医療経済学会第14回研究大会
- Data Source
  KAKENHI-PROJECT-17K08899
[Presentation] Cost-effectiveness of intravenous zoledronic acid compared with oral alendronate for elderly osteoporotic women in Japan2018
- Author(s)
  森　隆浩
- Organizer
  日本プライマリ・ケア連合学会学術大会
- Data Source
  KAKENHI-PROJECT-17K08899
[Presentation] 椎体骨折の既往のある骨折ハイリスク群の高齢女性を対象とした、テリパラチドに関する費用対効果分析2018
- Author(s)
  森　隆浩
- Organizer
  日本骨粗鬆症学会
- Data Source
  KAKENHI-PROJECT-17K08899

1. 田宮菜奈子 (20236748)

# of Collaborated Projects: 2 results

# of Collaborated Products: 4 results
2. 藤井朋子 (40793089)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results

Mori Takahiro 森 隆浩

Research Projects

Research Products

Co-Researchers

Fracture Prevention in a Super-Aging Society: Insights from Studies of Health Incurance Claims Data and Cost-Effectiveness AnalysisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

A Proposal for Effective Use and Reduction of Medical and Long-Term Care Expenditures: Big Data Analysis of Claims Data for Those Who Had Hip FracturePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Factors associated with non-initiation of osteoporosis pharmacotherapy after hip fracture: analysis of claims data in Japan2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cost-effectiveness of zoledronic acid versus oral alendronate for postmenopausal osteoporotic women in China2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Sequential Teriparatide/Alendronate versus Alendronate-only Strategies in High-risk Osteoporotic Women in the US: Analyzing the Impact of Generic or Biosimilar Teriparatide2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged ≧75 years and long-term care insurance claims data in Japan2018

Author(s)

Journal Title

DOI

Data Source

[Presentation] レセプトデータを用いた大腿骨近位部骨折後の骨粗鬆症薬物治療導入の有無に関連する要因の検討2023

Author(s)

Organizer

Data Source

[Presentation] Cost-effectiveness of alendronate for 10 years compared with 5 years in Japan,2019

Author(s)

Organizer

Data Source

[Presentation] Cost-effectiveness of sequential daily teriparatide/alendronate compared with alendronate alone for older osteoporotic women with prior vertebral fracture in Japan2019

Author(s)

Organizer

Data Source

[Presentation] Cost-effectiveness of intravenous zoledronic acid compared with oral alendronate for elderly osteoporotic women in Japan2018

Author(s)

Organizer

Data Source

[Presentation] 椎体骨折の既往のある骨折ハイリスク群の高齢女性を対象とした、テリパラチドに関する費用対効果分析2018

Author(s)

Organizer

Data Source

Mori Takahiro 森隆浩